Lv31
262 积分 2024-08-08 加入
A patent review of EZH2 inhibitors from 2017 and beyond
1个月前
已完结
Abstract LB419: HDAC8 over-expression promotes drug resistance and alters chromatin architecture in melanoma cells
1个月前
已完结
Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies
2个月前
已完结
Targeting the USP7-PRMT6 epigenetic axis overcomes chemoresistance in breast cancer by coordinating H3R2me2a deposition and RNF168 methylation for DNA repair and ferroptosis blockade
2个月前
已完结
Targeting the USP7-PRMT6 epigenetic axis overcomes chemoresistance in breast cancer by coordinating H3R2me2a deposition and RNF168 methylation for DNA repair and ferroptosis blockade
3个月前
已完结
Ubiquitin-Specific Protease 7 (USP7) as a Promising Therapeutic Target for Drug Discovery: From Mechanisms to Therapies
3个月前
已完结
Post-genomic illumination of paclitaxel biosynthesis
3个月前
已完结
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
3个月前
已完结
The molecular hallmarks of epigenetic control
3个月前
已完结
From 1957 to Nowadays: A Brief History of Epigenetics
3个月前
已关闭
皖公网安备34019202002308
